Cargando…
Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow
Nitric oxide (NO) maintains cardiovascular health by activating soluble guanylate cyclase (sGC) to increase cellular cGMP levels. Cardiovascular disease is characterized by decreased NO-sGC-cGMP signaling. Pharmacological activators and stimulators of sGC are being actively pursued as therapies for...
Autores principales: | Rogers, Natasha M., Seeger, Franziska, Garcin, Elsa D., Roberts, David D., Isenberg, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983488/ https://www.ncbi.nlm.nih.gov/pubmed/24772092 http://dx.doi.org/10.3389/fphys.2014.00134 |
Ejemplares similares
-
Biochemical and structural characterization of C-terminal constructs of bovine soluble guanylate cyclase
por: Seeger, Franziska, et al.
Publicado: (2011) -
Thrombospondin-1 is a universal inhibitor of soluble guanylate cyclase activation
por: Miller, Thomas W, et al.
Publicado: (2009) -
Soluble guanylate cyclase crystal clear: 1(st) crystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity
por: Seeger, Franziska, et al.
Publicado: (2013) -
Structural studies of soluble guanylate cyclase
por: Macdonald, Jane, et al.
Publicado: (2009) -
From biochemical and structural studies of soluble guanylate cyclase toward drug design
por: Laffly, Emmanuelle, et al.
Publicado: (2009)